← Leaderboards
Gregory A. Newby
Broad Institute, Inc.
$2,330,235
Attributed
$2,330,235
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,330,235 · 3
By mechanism
DP2$1,416,375 · 1
R00$747,000 · 1
K99$166,860 · 1
Top collaborators
No co-investigators on record.
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- David R Liu$34,362,066
- Amit Choudhary$8,194,699
- Mandana Arbab$2,392,778
Others in their field
Other Rising Stars on “Clinical Trials”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$46,538,640
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Suma Babu · Massachusetts General Hospital$36,168,406
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
Research focus
Clinical TrialsGenome EditingPrime EditorVariantRare DiseasesBase EditingIn VivoPrime EditingSuccessTissuesTherapeutic Genome EditingAllelesBase EditorMouse ModelGenetic DiseasesBrainAtac-SeqAdultBinding SitesBindingAnimal ModelDetectionChromatinDefect
Grant awards (5)
Generalizing genome editing for rare disease-causing variants$1,416,375
DP2 · FY2025 · OD · contact PI
In vivo precision genome editing to correct genetic disease$249,000
R00 · FY2025 · HL · contact PI
In vivo precision genome editing to correct genetic disease$249,000
R00 · FY2024 · HL · contact PI
In vivo precision genome editing to correct genetic disease$249,000
R00 · FY2023 · HL · contact PI
In vivo precision genome editing to correct genetic disease$166,860
K99 · FY2022 · HL · contact PI